AFM and cancer: The αIIb-β3 complex mediates the interaction between cancer cells and platelets [55], while the αL-β2 (LFA-1) and αM-β2 (Mac-1) complexes are responsible for the association of cancer cells to leukocytes [55], enabling EOC cells to exert immune responses.